jeudi 6 juillet 2023

FDA Makes Alzheimers Drug Leqembi Widely Accessible

The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.

from NYT > Health https://ift.tt/yfCjqRF
via health&fitness

Aucun commentaire:

Enregistrer un commentaire